These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 15979816

  • 1. Obesity and dose individualization in cancer chemotherapy: the role of body surface area and body mass index.
    Portugal RD.
    Med Hypotheses; 2005; 65(4):748-51. PubMed ID: 15979816
    [Abstract] [Full Text] [Related]

  • 2. Body surface area in normal-weight, overweight, and obese adults. A comparison study.
    Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L.
    Metabolism; 2006 Apr; 55(4):515-24. PubMed ID: 16546483
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A formula for the estimation of the body surface area of Saudi male adults.
    Nwoye LO, Al-Shehri MA.
    Saudi Med J; 2003 Dec; 24(12):1341-6. PubMed ID: 14710281
    [Abstract] [Full Text] [Related]

  • 6. Use of body surface area for assessing extracellular fluid volume and glomerular filtration rate in obesity.
    Peters AM, Glass DM.
    Am J Nephrol; 2010 Dec; 31(3):209-13. PubMed ID: 20029177
    [Abstract] [Full Text] [Related]

  • 7. Effect of body surface area calculations on body fat estimates in non-obese and obese subjects.
    Sardinha LB, Silva AM, Minderico CS, Teixeira PJ.
    Physiol Meas; 2006 Nov; 27(11):1197-209. PubMed ID: 17028412
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Obesity is not associated with increased myelosuppression in patients receiving chemotherapy for breast cancer.
    Jenkins P, Elyan S, Freeman S.
    Eur J Cancer; 2007 Feb; 43(3):544-8. PubMed ID: 17169553
    [Abstract] [Full Text] [Related]

  • 12. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Beier C, Dörr HG.
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [Abstract] [Full Text] [Related]

  • 13. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, Wolmark N.
    J Natl Cancer Inst; 2006 Nov 15; 98(22):1647-54. PubMed ID: 17105987
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. L-asparaginase as a marker of chemotherapy dose modification in children with acute lymphoblastic leukemia.
    Baillargeon J, Langevin AM, Lewis M, Thomas PJ, Mullins J, Dugan J, Pollock BH.
    Cancer; 2005 Dec 15; 104(12):2858-61. PubMed ID: 16288492
    [Abstract] [Full Text] [Related]

  • 16. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points.
    Majed B, Moreau T, Asselain B, Curie Institute Breast Cancer Group.
    Breast Cancer Res Treat; 2009 May 15; 115(1):193-203. PubMed ID: 18546073
    [Abstract] [Full Text] [Related]

  • 17. Optimal prescription method for cancer chemotherapy.
    Vriesendorp HM.
    Exp Hematol; 1985 May 15; 13 Suppl 16():57-63. PubMed ID: 3857184
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.